1,3-dipropyl-8-cyclopentylxanthine has been researched along with Cardiac Diseases in 2 studies
DPCPX : An oxopurine that is 7H-xanthine substituted at positions 1 and 3 by propyl groups and at position 8 by a cyclohexyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akgun, A | 1 |
| Kalkan, S | 1 |
| Hocaoglu, N | 1 |
| Gidener, S | 1 |
| Tuncok, Y | 1 |
| Böhm, M | 1 |
| Pieske, B | 1 |
| Ungerer, M | 1 |
| Erdmann, E | 1 |
2 other studies available for 1,3-dipropyl-8-cyclopentylxanthine and Cardiac Diseases
| Article | Year |
|---|---|
Effects of adenosine receptor antagonists on amitriptyline-induced QRS prolongation in isolated rat hearts.
Topics: Amitriptyline; Animals; Caffeine; Dose-Response Relationship, Drug; Heart; Heart Diseases; In Vitro | 2008 |
Characterization of A1 adenosine receptors in atrial and ventricular myocardium from diseased human hearts.
Topics: GTP-Binding Proteins; Heart; Heart Atria; Heart Diseases; Heart Ventricles; Humans; Kinetics; Male; | 1989 |